TaiMed Biologics Future Growth
Future criteria checks 0/6
TaiMed Biologics's earnings are forecast to decline at 0.07% per annum while its annual revenue is expected to grow at 5.4% per year. EPS is expected to decline by 0.2% per annum.
Key information
-0.07%
Earnings growth rate
-0.2%
EPS growth rate
| Biotechs earnings growth | 51.2% |
| Revenue growth rate | 5.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 30 Oct 2024 |
Recent future growth updates
Recent updates
TaiMed Biologics Inc.'s (GTSM:4147) Profit Outlook
Apr 20
TaiMed Biologics Inc. (GTSM:4147) Analysts Just Trimmed Their Revenue Forecasts By 18%
Mar 16TaiMed Biologics'(GTSM:4147) Share Price Is Down 67% Over The Past Five Years.
Feb 09Loss-Making TaiMed Biologics Inc. (GTSM:4147) Set To Breakeven
Jan 05
TaiMed Biologics (GTSM:4147) Has Debt But No Earnings; Should You Worry?
Dec 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 660 | -141 | -58 | -319 | 3 |
| 12/31/2024 | 615 | -138 | 7 | -45 | 3 |
| 9/30/2024 | 623 | -142 | 136 | 157 | N/A |
| 6/30/2024 | 642 | -110 | 107 | 120 | N/A |
| 3/31/2024 | 599 | -130 | 80 | 86 | N/A |
| 12/31/2023 | 492 | -195 | -32 | -26 | N/A |
| 9/30/2023 | 660 | -172 | -61 | -56 | N/A |
| 6/30/2023 | 599 | -202 | -104 | -99 | N/A |
| 3/31/2023 | 594 | -230 | -562 | -558 | N/A |
| 12/31/2022 | 563 | -269 | -610 | -605 | N/A |
| 9/30/2022 | 312 | -530 | -531 | -524 | N/A |
| 6/30/2022 | 307 | -572 | -515 | -505 | N/A |
| 3/31/2022 | 363 | -596 | -92 | -81 | N/A |
| 12/31/2021 | 413 | -471 | -225 | -211 | N/A |
| 9/30/2021 | 490 | -264 | -437 | -231 | N/A |
| 6/30/2021 | 551 | -233 | -471 | -222 | N/A |
| 3/31/2021 | 575 | -103 | -812 | -446 | N/A |
| 12/31/2020 | 722 | -183 | -588 | -202 | N/A |
| 9/30/2020 | 779 | -173 | -795 | -618 | N/A |
| 6/30/2020 | 839 | -450 | -1,023 | -815 | N/A |
| 3/31/2020 | 815 | -564 | -701 | -580 | N/A |
| 12/31/2019 | 705 | -579 | -793 | -655 | N/A |
| 9/30/2019 | 611 | -650 | -823 | -459 | N/A |
| 6/30/2019 | 486 | -684 | -840 | -489 | N/A |
| 3/31/2019 | 369 | -539 | -1,696 | -498 | N/A |
| 12/31/2018 | 241 | -322 | -1,708 | -523 | N/A |
| 9/30/2018 | 128 | -335 | -1,721 | -530 | N/A |
| 6/30/2018 | 43 | -83 | N/A | -523 | N/A |
| 3/31/2018 | 7 | -316 | N/A | -552 | N/A |
| 12/31/2017 | 8 | -525 | N/A | -516 | N/A |
| 9/30/2017 | 7 | -466 | N/A | -403 | N/A |
| 6/30/2017 | 5 | -410 | N/A | -223 | N/A |
| 3/31/2017 | 3 | -307 | N/A | -241 | N/A |
| 12/31/2016 | 2 | -282 | N/A | -172 | N/A |
| 9/30/2016 | 1 | -285 | N/A | -316 | N/A |
| 6/30/2016 | 1 | -423 | N/A | -392 | N/A |
| 3/31/2016 | 0 | -465 | N/A | -384 | N/A |
| 12/31/2015 | N/A | -472 | N/A | -446 | N/A |
| 9/30/2015 | N/A | -441 | N/A | -312 | N/A |
| 6/30/2015 | N/A | -333 | N/A | -230 | N/A |
| 3/31/2015 | N/A | -273 | N/A | -209 | N/A |
| 12/31/2014 | N/A | -282 | N/A | -213 | N/A |
| 9/30/2014 | N/A | -285 | N/A | -200 | N/A |
| 6/30/2014 | N/A | -289 | N/A | -215 | N/A |
| 3/31/2014 | N/A | -280 | N/A | -213 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4147 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 4147 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 4147 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 4147's revenue (5.4% per year) is forecast to grow slower than the TW market (12.5% per year).
High Growth Revenue: 4147's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4147's Return on Equity is forecast to be high in 3 years time